MarketPeel
Insider Trading Intelligence
ML

Mpm Asset Management Llc

AKTS
10% OWNER · AKTIS ONCOLOGY, INC. · CIK 0001263048
FILING MIX · LIFETIME13%/87%
BUYS
5
SELLS
34
TOTAL VALUE
$22.26M
COMPANIES
2
ACTIVE SINCE
Mar 2025
HOLDINGS NOW
4,784,111
AVG SELL PX
$1.15
TRADE KIND
SHOWING 39 / 39
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
30 backtested trades · 8 horizons · 60 pending
Forward-return performance of every backtestable P/S trade by Mpm Asset Management Llc, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d30+70.00%-6.83%-0.23%-6.59%-7.81%-3.02
14d30+60.00%-9.55%-0.19%-9.36%-9.54%-2.85
30d30+83.33%-20.92%+0.92%-21.84%-27.86%-7.50
60d30+93.33%-38.89%+1.94%-40.82%-44.48%-14.97
90d30+93.33%-36.10%+1.87%-37.97%-36.54%-15.35
180d30(1 pending)+96.55%-42.38%+8.61%-47.09%-51.83%
1y30(29 pending)+100.00%-27.01%+11.82%-38.83%-38.83%
2y30(30 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
AKTS · 0 shares · as of Jan 12, 2026
02,565,0165,130,0327,695,04810,260,064SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2025
2025
2025
2025
2026
FLOW · 5 buys / 34 sellsCOVERAGE · 5 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
AKTS
AKTIS ONCOLOGY, INC.
SALE
5,000,0000Jan 12, 2026Jan 14, 2026View →
AKTS
AKTIS ONCOLOGY, INC.
PURCHASE
1,112,777$18.00$20.03M10,260,064Jan 12, 2026Jan 14, 2026View →
AKTS
AKTIS ONCOLOGY, INC.
PURCHASE
5,914,1977,570,168Jan 12, 2026Jan 14, 2026View →
AKTS
AKTIS ONCOLOGY, INC.
PURCHASE
1,577,1199,147,287Jan 12, 2026Jan 14, 2026View →
AKTS
AKTIS ONCOLOGY, INC.
SALE
6,000,0000Jan 12, 2026Jan 14, 2026View →
AKTS
AKTIS ONCOLOGY, INC.
PURCHASE
1,314,2621,655,971Jan 12, 2026Jan 14, 2026View →
AKTS
AKTIS ONCOLOGY, INC.
SALE
22,500,0000Jan 12, 2026Jan 14, 2026View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
83,230$0.97$80.7K4,784,111Dec 4, 2025Dec 4, 2025View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
57,225$0.87$49.8K4,867,341Dec 3, 2025Dec 4, 2025View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
59,277$0.89$52.8K4,924,566Dec 2, 2025Dec 4, 2025View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
60,917$0.94$57.3K4,983,843Dec 1, 2025Dec 1, 2025View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
20,277$0.99$20.1K5,044,760Nov 28, 2025Dec 1, 2025View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
60,733$0.98$59.5K5,065,037Nov 26, 2025Dec 1, 2025View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
42,533$0.92$39.1K5,125,770Nov 25, 2025Nov 25, 2025View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
88,802$0.98$87.0K5,168,303Nov 24, 2025Nov 25, 2025View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
64,331$0.83$53.4K5,257,105Nov 21, 2025Nov 25, 2025View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
41,152$0.89$36.6K5,321,436Nov 20, 2025Nov 20, 2025View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
66,324$0.94$62.3K5,362,588Nov 19, 2025Nov 20, 2025View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
52,627$0.93$48.9K5,428,912Nov 18, 2025Nov 20, 2025View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
57,061$0.95$54.2K5,481,539Nov 17, 2025Nov 17, 2025View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
61,640$0.93$57.3K5,538,600Nov 14, 2025Nov 17, 2025View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
90,951$0.98$89.1K5,600,240Nov 13, 2025Nov 17, 2025View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
40,669$1.09$44.3K5,691,191Nov 12, 2025Nov 12, 2025View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
55,810$1.14$63.6K5,731,860Nov 11, 2025Nov 12, 2025View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
48,570$1.18$57.3K5,787,670Nov 10, 2025Nov 12, 2025View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
68,480$1.11$76.0K5,836,240Nov 7, 2025Nov 12, 2025View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
54,452$1.21$65.9K5,904,720Nov 6, 2025Nov 6, 2025View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
47,950$1.22$58.5K5,959,172Nov 5, 2025Nov 6, 2025View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
140,488$1.22$171.4K6,007,122Nov 4, 2025Nov 6, 2025View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
94,063$1.29$121.3K6,147,610Nov 3, 2025Nov 3, 2025View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
114,044$1.28$146.0K6,241,673Oct 31, 2025Nov 3, 2025View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
86,936$1.43$124.3K6,355,717Oct 30, 2025Nov 3, 2025View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
134,240$1.55$208.1K6,442,653Oct 29, 2025Oct 29, 2025View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
69,068$1.64$113.3K6,576,893Oct 28, 2025Oct 29, 2025View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
72,709$1.72$125.1K6,645,961Oct 27, 2025Oct 29, 2025View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE
4,386$1.05$4.6K6,718,670Mar 27, 2025Apr 30, 2025View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE
42,8420Mar 27, 2025Apr 30, 2025View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE
8,0310Mar 27, 2025Apr 30, 2025View →
HOWL
WEREWOLF THERAPEUTICS, INC.
PURCHASE
50,873$0.09$4.6K6,723,056Mar 27, 2025Apr 30, 2025View →
Other insiders · AKTS
Loading peer insiders…
About this filer
CIK 0001263048
ROLE
10% Owner
PRIMARY
AKTS
COMPANIES
2
ACTIVE SINCE
Mar 2025
MARKETPEEL · /INSIDER/0001263048DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback